Assessment of vasomotor endothelial function in patients with diabetes mellitus type 1 at different stages of diabetic nephropathy

被引:0
|
作者
Shestakova, MV [1 ]
Yarek-Martynov, IR
Ivanishina, NS
Dedov, II
机构
[1] Russian Acad Med Sci, Endocrinol Res Ctr, Moscow, Russia
[2] Minist Publ Hlth Russia, Prevent Med State Res Ctr, Moscow, Russia
关键词
diabetes mellitits type 1; diabetic nephropathy; vasomotor function of the endothelium; endothelitis; reactive hyperemia;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aim. To study a vasomotor endothelial function in patients with diabetes mellitus (DM) type I at different stages of diabetic nephropathy (DN). Material and methods. Twenty six patients with DM type I (I I males and 15 females, mean age 25.9 +/- 4.3 years, mean history of DM 12.9 +/- 3.4 years) entered the study. They were divided into 4 groups: group I -without renal affection, group 2 - with microalbuminuria (MAU), group 3 - with proteinuria (PU), group 4 - with chronic renal failure (CRF). The control group consisted of 7 healthy volunteers. Endothelium-dependent vasodilation (EDVD) was studied in the test with reactive hyperemia provoked by 4-5 min occlusion of the brachial artery by pneumocollar and subsequent assessment of arterial diameter changes after decompression using high-resolution ultrasound dopplerography. Results. Reactive hyperemia resulted in dilation of the artery in all the examinees. This dilation was maximal on second 30 after removal of the collar in the controls, group 2, 3 and 4 and reached 9.2 +/- 2.9, 9.63 +/- 3.62, 725 +/- 5.23 and 4.42 +/- 4.05%, respectively. Resting bloodflow velocity was similar in all the groups and-rose maximally by 95-150%. To estimate EDVD of the brachial artery more precisely, the coefficient of endothelial sensitivity to shift tension was calculated. It made up 0.084 +/- 0.04 (control group), 0.0825 +/- 0.08 (group 1), 0.138 +/- 0.07 (group 2), 0.067 +/- 0.05 (group 3) and 0.052 +/- 0.04 (group 4). Conclusion. At the earliest stage of DN (stage MAU), EDVD is not affected as maximal vasodilation of the brachial artery and endothelial sensitivity to shift tension do not differ from the control values. This means that the stage of MA U is reversible in early treatment, but PU and CRF are not reversible stages associated with depletion of endothelial cells and loss of sensitivity to changing hemodynamic conditions.
引用
收藏
页码:17 / 21
页数:5
相关论文
共 50 条
  • [21] Diabetic Nephropathy in Patients with Type 1 Diabetes Mellitus. Contribution of the Metabolic Syndrome
    Uribe-Wiechers, Ana C.
    Almeda-Valdes, Paloma
    Janka, Marcela
    Lopez-Gutierrez, Joel
    Javier Gomez-Perez, Francisco
    ENDOCRINE REVIEWS, 2014, 35 (03)
  • [22] Age at Diagnosis and the Risk of Diabetic Nephropathy in Young Patients with Type 1 Diabetes Mellitus
    Baek, Jong Ha
    Lee, Woo Je
    Lee, Byung-Wan
    Kim, Soo Kyoung
    Kim, Gyuri
    Jin, Sang-Man
    Kim, Jae Hyeon
    DIABETES & METABOLISM JOURNAL, 2021, 45 (01) : 46 - 54
  • [23] Assessment of the diagnostic value of different biomarkers in relation to various stages of diabetic nephropathy in type 2 diabetic patients
    Al-Rubeaan, Khalid
    Siddiqui, Khalid
    Al-Ghonaim, Mohammed A.
    Youssef, Amira M.
    Al-Sharqawi, Ahmed H.
    AlNaqeb, Dhekra
    SCIENTIFIC REPORTS, 2017, 7
  • [24] Assessment of the diagnostic value of different biomarkers in relation to various stages of diabetic nephropathy in type 2 diabetic patients
    Khalid Al-Rubeaan
    Khalid Siddiqui
    Mohammed A. Al-Ghonaim
    Amira M. Youssef
    Ahmed H. Al-Sharqawi
    Dhekra AlNaqeb
    Scientific Reports, 7
  • [25] Evolutive assessment of endothelial function in metabolic control and microvascular complications in type 1 diabetes mellitus patients
    Winston Boff
    Antonio Marcos Vargas da Silva
    Marcia Puñales
    Gislaine Vissoky Cé
    Marcello Casaccia Bertoluci
    Diabetology & Metabolic Syndrome, 7 (Suppl 1):
  • [26] Complex assessment of episodes of ischemia and vasomotor function of vascular endothelium in patients with type II diabetes mellitus
    Tatartchenko, I. P.
    Pozdnyakova, N. V.
    Dudukina, E. A.
    Morozova, O. I.
    KARDIOLOGIYA, 2007, 47 (04) : 28 - 31
  • [27] Progression of diabetic nephropathy in Saudi patients with type 2 diabetes mellitus
    Al Suleiman, Mohamed H.
    Kfoury, Hala K.
    Jondeby, Mohamed S.
    Burgos, Noel S.
    Al Hayyan, Hajjar
    Al Sayyari, Abdulla
    ENDOCRINOLOGIST, 2008, 18 (05): : 230 - 232
  • [28] Diabetic nephropathy and myocardial lesions in children with type 1 diabetes mellitus
    Kazakova, L. V.
    Azova, E. A.
    Lukushkina, E. F.
    Strongin, L. G.
    DIABETES MELLITUS, 2009, 12 (03): : 43 - 48
  • [29] Early onset of diabetic nephropathy in a child with type 1 diabetes mellitus
    Bayazit, AK
    Yüksel, B
    Noyan, A
    Önenli, N
    Gönlüsen, G
    Özer, G
    Anarat, A
    TURKISH JOURNAL OF PEDIATRICS, 2003, 45 (01) : 55 - 58
  • [30] Identification of the locus associated with diabetic nephropathy in type 1 diabetes mellitus
    Savost'yanov, KV
    Chistyakov, DA
    Shestakova, MV
    Voron'ko, OE
    Chugunova, LA
    Shamkhalova, MS
    Dedov, II
    Nosikov, VV
    MOLECULAR BIOLOGY, 2002, 36 (06) : 823 - 827